Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis.
about
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue diseaseHealth-related quality of life in patients with pulmonary arterial hypertensionPulmonary Hypertension and Indicators of Right Ventricular FunctionVascular Remodelling and Mesenchymal Transition in Systemic SclerosisRight ventricular adaptation and failure in pulmonary arterial hypertension.Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertensionThe right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury.Determinants of right ventricular ejection fraction in pulmonary arterial hypertension.Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fractionTherapy for pulmonary arterial hypertension associated with systemic sclerosis.From short-term benefits to long-term outcomes: the evolution of clinical trials in pulmonary arterial hypertensionDiagnosis and management of pulmonary hypertension in systemic sclerosis.Scleroderma lung diseaseSystemic sclerosis-associated pulmonary arterial hypertensionSaudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseasesPulmonary hypertension surveillance: United States, 2001 to 2010Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.Pulmonary venous occlusion and death in pulmonary arterial hypertension: survival analyses using radiographic surrogates.Life span of patients with Eisenmenger syndrome is not superior to that of patients with other causes of pulmonary hypertension.Lung involvement in systemic sclerosis.An official American Thoracic Society Statement: pulmonary hypertension phenotypesPulmonary arterial hypertension associated with systemic sclerosis.Connective tissue disease-associated pulmonary arterial hypertension.Pulmonary artery smooth muscle cell endothelin-1 expression modulates the pulmonary vascular response to chronic hypoxiaPlatelet-derived growth factor receptor-β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive dThe right ventricle in scleroderma (2013 Grover Conference Series).A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonismPulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population.NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity.Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.Systemic sclerosis associated pulmonary hypertension: improved survival in the current era.Surrogate end points in pulmonary arterial hypertension: assessing the response to therapy.Effects of ranolazine on exercise capacity, right ventricular indices, and hemodynamic characteristics in pulmonary arterial hypertension: a pilot studyPulmonary arterial hypertension in connective tissue diseases.Clinical trials in systemic sclerosis: lessons learned and outcomes.Current treatment strategies for pulmonary arterial hypertension.Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.Comparison of Treatment Response in Idiopathic and Connective Tissue Disease-associated Pulmonary Arterial HypertensionRight ventricular thickness as predictor of global myocardial performance in systemic sclerosis: A Doppler tissue imaging study.
P2860
Q24681558-153094C0-FF1A-46E6-8027-498E5534BA8FQ24814151-DB765E24-163F-420D-BC0C-29C4AB06853EQ26744781-C3E28231-C8BA-43B8-909D-AD7E0B96A62AQ26749091-6BA9F5FE-2471-4341-A5F3-530C736DB43EQ27318422-32F51222-6309-456D-81A8-64440AECE280Q28083183-3FEBDC47-E30D-4BCC-A003-F024962DD746Q30585014-AD081BD2-23CD-47BD-B096-752B7F2BD4A1Q33681073-B8663D3B-0E9D-4170-8564-3B011D4E2525Q33712182-0CA6191F-FA73-4759-A782-1D0608109048Q33788474-D4AA6540-8EC8-4D9E-802C-F6D5D774071EQ33805746-65F54577-A82A-4525-95B2-3D376FB1F883Q33806102-D2FD3C61-8E0B-4590-88E9-AD1A2155F042Q33832379-16660805-500C-48E4-BE96-E6988C4DB1D6Q33919119-ADB5E68E-EA13-4810-BB72-2021EA12EC58Q33950086-EFEB975F-B03A-4B7F-8DE5-8F91B5491A05Q33965825-27B58449-7A05-4962-A2B0-5A64A827AAD4Q34004369-1F95BF76-8FEB-407C-A0FD-9ED845A10EA6Q34032884-C6858AD1-AC26-4BFD-8149-F87EBC77F535Q34040866-39627684-7302-4CC1-9A42-446236812FD8Q34457779-BC45CDC8-08CA-4C3D-A917-C13C4DBC31EFQ34732817-C9AF0CED-0438-45AC-9837-8EF94E10D501Q34919733-F47A5C15-F845-4F06-A8A8-83EE47D566E8Q35002423-168DA24B-293E-41F1-9714-359A05DA60D1Q35029607-AA80F6F8-31E5-452F-ADA0-68DC0F263AE8Q35086382-4AEFD246-72C9-4C20-8FF5-80251CC79F80Q35093008-F5B348C8-3E34-4FF2-B086-134E8E6348B2Q35517421-87DD355F-BBC7-4DDB-8621-579B7F909FC9Q35554571-E87FB730-9FEB-4F10-B3B5-93C5BC5534C5Q35591616-36E97091-3B16-4EA3-BEF5-73C55D2A3EC3Q35605567-8CEC5FD4-346B-45C4-A23B-7E87C0928709Q35637949-FBECBE9E-80D0-4C7C-A08D-D450B13660E7Q35771091-A99DA40C-964C-49FE-B3C3-B691E34DB233Q35792872-7D440EF9-6BF2-462E-B508-B636704346C8Q36016535-542500B9-BA0A-4D84-806F-5517D50FE15DQ36075852-5DE5BA9D-EBFA-45F5-AF3E-1200C49067CEQ36130965-BEC9E0C3-F5E8-4659-A6A5-DC6E1406162AQ36237720-88B10111-9B3B-47CD-8B9D-1AC25BE0ECD8Q36272405-D745A84F-8901-48DE-A63A-3DC7D655B9C5Q36272410-63908556-4DE4-4E7B-A8B6-85EF7927055BQ36426633-0F2D9384-21D5-41E9-B753-C9EFB99884E0
P2860
Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Hemodynamics and survival in p ...... related to systemic sclerosis.
@en
type
label
Hemodynamics and survival in p ...... related to systemic sclerosis.
@en
prefLabel
Hemodynamics and survival in p ...... related to systemic sclerosis.
@en
P2093
P356
P1433
P1476
Hemodynamics and survival in p ...... related to systemic sclerosis.
@en
P2093
Christine L Archer-Chicko
Harold I Palevsky
Stephen E Kimmel
Steven M Kawut
P304
P356
10.1378/CHEST.123.2.344
P407
P577
2003-02-01T00:00:00Z